sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Patient Information Leaflet last updated on the eMC: 29/03/2011
PIL Phenergan Elixir

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 29/03/2011 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
Updated on 19/03/2010 and displayed until 29/03/2011
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 21/07/2008 and displayed until 19/03/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 29/04/2008 and displayed until 21/07/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 24/09/2007 and displayed until 29/04/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change of contra-indications
Updated on 18/08/2006 and displayed until 24/09/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 29/11/2000 and displayed until 18/08/2006
Reasons for adding or updating:
  • No reasons supplied
Updated on 09/08/2000 and displayed until 29/11/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   promethazine hydrochloride